Literature DB >> 22396608

No evidence for association of Chr 9p21 variant rs1333049 with gout in New Zealand case-control sample sets.

Angela Hsu, Nicola Dalbeth, Peter Gow, Andrew Harrison, John Highton, Peter B Jones, Lisa K Stamp, Tony R Merriman.   

Abstract

Entities:  

Mesh：

Year:  2012        PMID： 22396608      PMCID： PMC3465700          DOI： 10.1093/rheumatology/kes029

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN： 1462-0324            Impact factor:   7.580


× No keyword cloud information.
  10 in total

1.  Forearm vasodilator reactivity in homozygous carriers of the 9p21.3 rs1333049 G>C polymorphism.

Authors:  Stefan Aschauer; Friedrich Mittermayer; Claudia C Wagner; Wolfgang M Schmidt; Martin Brunner; Helmuth Haslacher; Michael Wolzt; Markus Müller
Journal:  Eur J Clin Invest       Date:  2010-08       Impact factor: 4.686

Review 2.  The genetic basis of hyperuricaemia and gout.

Authors:  Tony R Merriman; Nicola Dalbeth
Journal:  Joint Bone Spine       Date:  2010-05-15       Impact factor: 4.929

3.  Genetic association of polymorphism rs1333049 with gout.

Authors:  Binbin Wang; Dongmei Meng; Jing Wang; Shiguo Liu; Sirui Zhou; Zhimin Miao; Lin Han; Nan Chu; Kun Zhang; Xu Ma; Changgui Li
Journal:  Rheumatology (Oxford)       Date:  2011-05-09       Impact factor: 7.580

4.  Multiple genetic loci influence serum urate levels and their relationship with gout and cardiovascular disease risk factors.

Authors:  Qiong Yang; Anna Köttgen; Abbas Dehghan; Albert V Smith; Nicole L Glazer; Ming-Huei Chen; Daniel I Chasman; Thor Aspelund; Gudny Eiriksdottir; Tamara B Harris; Lenore Launer; Michael Nalls; Dena Hernandez; Dan E Arking; Eric Boerwinkle; Megan L Grove; Man Li; W H Linda Kao; Michel Chonchol; Talin Haritunians; Guo Li; Thomas Lumley; Bruce M Psaty; Michael Shlipak; Shih-Jen Hwang; Martin G Larson; Christopher J O'Donnell; Ashish Upadhyay; Cornelia M van Duijn; Albert Hofman; Fernando Rivadeneira; Bruno Stricker; Andre G Uitterlinden; Guillaume Paré; Alex N Parker; Paul M Ridker; David S Siscovick; Vilmundur Gudnason; Jacqueline C Witteman; Caroline S Fox; Josef Coresh
Journal:  Circ Cardiovasc Genet       Date:  2010-09-30

5.  A strong role for the ABCG2 gene in susceptibility to gout in New Zealand Pacific Island and Caucasian, but not Māori, case and control sample sets.

Authors:  Amanda J Phipps-Green; Jade E Hollis-Moffatt; Nicola Dalbeth; Marilyn E Merriman; Ruth Topless; Peter J Gow; Andrew A Harrison; John Highton; Peter B B Jones; Lisa K Stamp; Tony R Merriman
Journal:  Hum Mol Genet       Date:  2010-09-21       Impact factor: 6.150

6.  A common allele on chromosome 9 associated with coronary heart disease.

Authors:  Ruth McPherson; Alexander Pertsemlidis; Nihan Kavaslar; Alexandre Stewart; Robert Roberts; David R Cox; David A Hinds; Len A Pennacchio; Anne Tybjaerg-Hansen; Aaron R Folsom; Eric Boerwinkle; Helen H Hobbs; Jonathan C Cohen
Journal:  Science       Date:  2007-05-03       Impact factor: 47.728

7.  Role of the urate transporter SLC2A9 gene in susceptibility to gout in New Zealand Māori, Pacific Island, and Caucasian case-control sample sets.

Authors:  Jade E Hollis-Moffatt; Xin Xu; Nicola Dalbeth; Marilyn E Merriman; Ruth Topless; Chloe Waddell; Peter J Gow; Andrew A Harrison; John Highton; Peter B B Jones; Lisa K Stamp; Tony R Merriman
Journal:  Arthritis Rheum       Date:  2009-11

Review 8.  Epidemiology of gout.

Authors:  Edward Roddy; Michael Doherty
Journal:  Arthritis Res Ther       Date:  2010-12-21       Impact factor: 5.156

9.  9p21 DNA variants associated with coronary artery disease impair interferon-γ signalling response.

Authors:  Olivier Harismendy; Dimple Notani; Xiaoyuan Song; Nazli G Rahim; Bogdan Tanasa; Nathaniel Heintzman; Bing Ren; Xiang-Dong Fu; Eric J Topol; Michael G Rosenfeld; Kelly A Frazer
Journal:  Nature       Date:  2011-02-10       Impact factor: 49.962

10.  Genomewide association analysis of coronary artery disease.

Authors:  Nilesh J Samani; Jeanette Erdmann; Alistair S Hall; Christian Hengstenberg; Massimo Mangino; Bjoern Mayer; Richard J Dixon; Thomas Meitinger; Peter Braund; H-Erich Wichmann; Jennifer H Barrett; Inke R König; Suzanne E Stevens; Silke Szymczak; David-Alexandre Tregouet; Mark M Iles; Friedrich Pahlke; Helen Pollard; Wolfgang Lieb; Francois Cambien; Marcus Fischer; Willem Ouwehand; Stefan Blankenberg; Anthony J Balmforth; Andrea Baessler; Stephen G Ball; Tim M Strom; Ingrid Braenne; Christian Gieger; Panos Deloukas; Martin D Tobin; Andreas Ziegler; John R Thompson; Heribert Schunkert
Journal:  N Engl J Med       Date:  2007-07-18       Impact factor: 91.245
  10 in total
  2 in total

1.  New findings in the roles of Cyclin-dependent Kinase inhibitors 2B Antisense RNA 1 (CDKN2B-AS1) rs1333049 G/C and rs4977574 A/G variants on the risk to coronary heart disease.

Authors:  Wei Yuan; Wei Zhang; Wei Zhang; Zhong-Bao Ruan; Li Zhu; Yu Liu; Yuan-Yuan Mi; Li-Feng Zhang
Journal:  Bioengineered       Date:  2020-12       Impact factor: 3.269

2.  Effects of CDKN2B-AS1 polymorphisms on the susceptibility to coronary heart disease.

Authors:  Kang Huang; Jianghua Zhong; Qiang Li; Wei Zhang; Zibin Chen; Yilei Zhou; Miao Wu; Zanrui Zhong; Shijuan Lu; Shufang Zhang
Journal:  Mol Genet Genomic Med       Date:  2019-09-08       Impact factor: 2.183
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.